• Science and Research

  Australia Approves Symdeko for Patients 12 and Older with Cystic Fibrosis

  Posted by Cystic Fibrosis News Moderator on March 24, 2019 at 11:44 am

  Cystic fibrosis patients in Australia 12 or older who have two copies of the F508del mutation in the CFTR gene can now be treated with Symdeko. Click here to read the full story.

  What are your thoughts on this news?

  Cystic Fibrosis News Moderator replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply